ScPharmaceuticals Announces Co Is Targeting February 20, 2023 As The Date For Commercial Availability Of FUROSCIX
scPharmaceuticals Inc. (NASDAQ:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today